Our first ever hybrid Therapeutics Symposium was held at the end of June and we were thrilled to welcome over 350 delegates at West Road Concert Hall, with a further 200+ delegates opting to view the talks via the online symposium platform! A selection of photographs from the day are now available to view at this page.
The day began with an in-person Meet the Consortium session, where our pharma partners met with registered attendees from academia, affiliated companies and institutions. Several interesting connections were made and we look forward to seeing what collaborative opportunities comes of them over the coming year.
Our Director Tony Kouzarides kicked off the main event with a fantastic introduction to the Milner Therapeutics Institute – describing our mission and the different ways we work to achieve it. The talk is available to view on our YouTube channel.
During the plenary session, outstanding talks from Kristian Helin, Guilia Biffi, Lori Passmore, Simon Boulton, Andras Lakatos and Ravindra Gupta highlighted exceptional progress in understanding of disease mechanisms and therapeutic approaches across oncology, neuroscience and infectious disease. Two talks also provided excellent examples of powerful partnerships in action. Matthias Zilbauer’s talk on organoid models of inflammatory bowel disease highlighted a collaboration with the MTI Target Discovery group, while Richard Hargreaves’ talk outlined how Bristol Myers Squibb have created a successful external research network to facilitate neuroscience drug discovery.
Later in the afternoon, delegates joined a discussion with diverse and experienced panel members, highlighting what successful partnerships have looked like for them, and how we can work toward maximising collaborative potential across sectors. You can continue the discussion around interdisciplinary collaborations on Connect: Health Tech.
The Symposium ended with a bustling networking reception, where delegates had the opportunity to form new connections and view posters from throughout academia and industry. We were thrilled to welcome delegates in person once again, and are already looking forward to next year!